Unique ID issued by UMIN | UMIN000021962 |
---|---|
Receipt number | R000025156 |
Scientific Title | The effect of intake of Okinawa ingredients (Peucedanum japonicum) on lipid metabolism |
Date of disclosure of the study information | 2016/06/01 |
Last modified on | 2017/04/11 14:05:16 |
The effect of intake of Okinawa ingredients (Peucedanum japonicum) on lipid metabolism
The effect of intake of Okinawa ingredients (Peucedanum japonicum) on lipid metabolism
The effect of intake of Okinawa ingredients (Peucedanum japonicum) on lipid metabolism
The effect of intake of Okinawa ingredients (Peucedanum japonicum) on lipid metabolism
Japan |
healthy subject
Adult |
Others
NO
We will examine the impact on lipid metabolism of the Peucedanum japonicum.
Efficacy
This test verifies the change over time in the total cholesterol, triglyceride, LDL cholesterol, body weight, body fat and Body Mass Index.(Before intake, after intake 4weeks, after intake 8weeks and after intake 12 weeks)
This test is to verify the change in the serum adiponectin.(Before intake, after intake 4weeks, after intake 8weeks and after intake 12 weeks)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Subjects takes the 12-week test food. The evaluation is carried out every four weeks.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1.Japanese men and women from 20 years old to 80 years old
2.Those who fully understand and document agreed by free will of the subject person was obtained after having received a sufficient explanation of the study
3.Below, corresponding to either subjects
-LDL cholesterol level is borderline and person of mild range (120-159mg/dL)
-Who triglyceride levels of the high-normal range, and slightly higher(120-199mg/dL)
1.Those who are routinely regular use "Peucedanum japonicum"
2.Excessive smoking and alcohol addicts as well as the diet is extremely irregular person
3.Those of serious diseases currently in treatment
4.Diabetes, liver disease, kidney disease, who underlying disease, such as heart disease that need is urgent treatment in serious condition
5.Those with a history of food allergies
6.A person with a plan of pregnancy during the lactation period and the person or test period during pregnancy
7.A person who has been determined to be inappropriate as a subject in the results of the screening
8.Others, who investigators were ineligible
25
1st name | |
Middle name | |
Last name | Satoshi Ohno |
Osaka University Graduate School of Medicine
Department of Integrative Medicine
2-2, Yamadaoka, Suita, OSAKA
06-6879-3498
ohno@cam.med.osaka-u.ac.jp
1st name | |
Middle name | |
Last name | Miki Sakaue |
Osaka University Graduate School of Medicine
Department of Integrative Medicine
2-2, Yamadaoka, Suita, OSAKA
06-6879-3498
mikity@cam.med.osaka-u.ac.jp
Department of Integrative Medicine, Osaka University Graduate School of Medicine
Okinawa TLO Ltd.
Other
NO
2016 | Year | 06 | Month | 01 | Day |
Unpublished
Completed
2016 | Year | 04 | Month | 13 | Day |
2016 | Year | 06 | Month | 01 | Day |
2016 | Year | 04 | Month | 18 | Day |
2017 | Year | 04 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025156